Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Zoom
ZM
|
$1.14B |
| 2 |
AbbVie
ABBV
|
$537M |
| 3 |
T-Mobile US
TMUS
|
$504M |
| 4 |
Baidu
BIDU
|
$474M |
| 5 |
Kroger
KR
|
$448M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$1.32B |
| 2 |
AGN
Allergan plc
AGN
|
$1.26B |
| 3 |
S
Sprint Corporation
S
|
$675M |
| 4 |
Amgen
AMGN
|
$504M |
| 5 |
Humana
HUM
|
$466M |
Sector Composition
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.11% |
| 3 | Consumer Staples | 10.59% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
United Microelectronic
UMC
$17.1B
| $50.4M | 0.04% |
19,102,139
+942,659
| +5% | +$2.49M |
|
427
Sumitomo Mitsui Financial
SMFG
$105B
| $50.3M | 0.04% |
8,945,070
-177,700
| -2% | -$999K |
|
428
OGE Energy
OGE
$8.89B
| $50.3M | 0.04% |
1,655,764
-344,797
| -17% | -$10.5M |
|
429
Diageo
DEO
$61.3B
| $50.2M | 0.04% |
373,733
+14,133
| +4% | +$1.9M |
|
430
Illumina
ILMN
$15.7B
| $50M | 0.04% |
138,910
+137,985
| +14,917% | +$49.7M |
|
431
COPT Defense Properties
CDP
$3.46B
| $49.8M | 0.04% |
1,964,888
-767,000
| -28% | -$19.4M |
|
432
Lockheed Martin
LMT
$108B
| $49.6M | 0.04% |
135,800
-7,622
| -5% | -$2.78M |
|
433
Keurig Dr Pepper
KDP
$38.9B
| $49M | 0.04% |
1,726,381
+1,212,281
| +236% | +$34.4M |
|
434
Annaly Capital Management
NLY
$14.2B
| $48.8M | 0.04% |
1,859,791
-1,112,075
| -37% | -$29.2M |
|
|
TARO
435
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $48.8M | 0.04% |
733,600
+67,600
| +10% | +$4.49M |
|
436
Radware
RDWR
$1.07B
| $48.6M | 0.04% |
2,061,339
+179,100
| +10% | +$4.22M |
|
437
Kearny Financial
KRNY
$415M
| $48.5M | 0.04% |
5,923,609
+23,090
| +0.4% | +$189K |
|
438
British American Tobacco
BTI
$122B
| $48.4M | 0.04% |
1,247,154
+50,601
| +4% | +$1.96M |
|
439
Vanda Pharmaceuticals
VNDA
$272M
| $48.4M | 0.04% |
4,229,822
+380,168
| +10% | +$4.35M |
|
440
WSFS Financial
WSFS
$3.26B
| $48.3M | 0.04% |
1,683,631
-342,631
| -17% | -$9.83M |
|
|
EGOV
441
DELISTED
NIC Inc
EGOV
| $48.2M | 0.04% |
2,098,132
+334,760
| +19% | +$7.69M |
|
442
Boston Properties
BXP
$12.2B
| $47.9M | 0.04% |
530,400
+131,503
| +33% | +$11.9M |
|
443
Crown Castle
CCI
$41.9B
| $47.9M | 0.04% |
286,303
-1,422,288
| -83% | -$238M |
|
444
Vale
VALE
$44.4B
| $47.6M | 0.04% |
4,618,390
-17,005,259
| -79% | -$175M |
|
445
Enanta Pharmaceuticals
ENTA
$189M
| $47.3M | 0.04% |
942,900
+62,300
| +7% | +$3.13M |
|
446
Abbott
ABT
$231B
| $47.2M | 0.04% |
+515,966
| New | +$47.2M |
|
447
AT&T
T
$212B
| $47M | 0.04% |
2,057,610
-11,506,089
| -85% | -$263M |
|
|
CAJ
448
DELISTED
Canon, Inc.
CAJ
| $46.9M | 0.04% |
2,348,977
+699,470
| +42% | +$14M |
|
449
3M
MMM
$82.7B
| $46.8M | 0.04% |
+358,680
| New | +$46.8M |
|
450
Alcoa
AA
$8.24B
| $46.8M | 0.04% |
4,160,688
-2,804,200
| -40% | -$31.5M |
|